Biodexa Pharmaceuticals (BDRX) Current Assets (2013 - 2026)
Biodexa Pharmaceuticals (BDRX) reported Current Assets of $8.98 million for the quarter ended Jun 30, 2026, down 25.2% from $12 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Current Assets (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals posted Current Assets of $16.41 million, up 45.7% from the prior year.
- Current Assets has increased for three consecutive years, with a five-year compound annual growth rate of 6.6% (years ended Dec 2020 to Dec 2025).
- By year, Current Assets came in at $11.26 million in the year ended Dec 31, 2024 (+28.8%), $8.74 million in the year ended Dec 31, 2023 (+50.7%), $5.8 million in the year ended Dec 31, 2022 (-64.1%) and $16.18 million in the year ended Dec 31, 2021 (+35.9%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Current Assets since the quarter ended Dec 31, 2023.
- Year over year, Current Assets gained in three of the last four quarters, with growth averaging 19.3%.
- The high point for year-over-year Current Assets in five years was the quarter ended Dec 31, 2023 (growth of 58.7%); the low point was the quarter ended Dec 31, 2022 (a decline of 65.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Biodexa Pharmaceuticals | 3,915.67 | -23.40 Mn | - | 8.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.87 Mn |
| Dec 31, 2025 | 16.76 Mn |
| Jun 30, 2025 | 12.34 Mn |
| Dec 31, 2024 | 11.06 Mn |
| Jun 30, 2024 | 9.51 Mn |
| Dec 31, 2023 | 8.95 Mn |
| Jun 30, 2023 | 9.16 Mn |
| Dec 31, 2022 | 5.65 Mn |
| Dec 31, 2021 | 15.88 Mn |
| Jun 30, 2021 | 9.73 Mn |
| Dec 31, 2020 | 12.64 Mn |
| Jun 30, 2020 | 12.64 Mn |
| Dec 31, 2019 | 18.01 Mn |
| Jun 30, 2019 | 18.16 Mn |
| Dec 31, 2018 | 7.13 Mn |
| Jun 30, 2018 | 26.79 Mn |
| Dec 31, 2017 | 24.98 Mn |
| Jun 30, 2017 | 15.23 Mn |
| Dec 31, 2016 | 27.41 Mn |
| Jun 30, 2016 | 15.13 Mn |
API Access
Biodexa Pharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();